Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
5 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.

Eosinophilic oesophagitis a late manifestation of atopic march in children

Roshini Claire Anthony
23 Mar 2018

Eosinophilic oesophagitis appears to be a late manifestation of the atopic march, according to a study presented at the recent 2018 AAAAI/WAO* congress held in Orlando, Florida, US.

“The atopic march describes the natural development of atopic dermatitis, IgE-mediated food allergy, asthma, and allergic rhinitis,” said the researchers.

“Our findings indicate that eosinophilic oesophagitis falls into the pattern of atopic march, although eosinophilic oesophagitis tends to be diagnosed later in the progression,” said study author Professor Jonathan Spergel from the Children’s Hospital of Philadelphia, Pennsylvania, US.

In this case-control study, data of 130,457 children (aged <1 year at database entry) were evaluated to identify a potential link between atopic dermatitis, IgE-mediated food allergy, asthma, or allergic rhinitis and the risk of developing eosinophilic oesophagitis.

Over a follow-up period of ≥24 months, 139 children developed eosinophilic oesophagitis, with a prevalence of 0.11 percent. Male and Caucasian children appeared to be at an elevated risk of developing eosinophilic oesophagitis compared with other groups (odds ratio, 2.7 and 2.4, respectively).

The peak age for a diagnosis of eosinophilic oesophagitis was 2.7 years which was lower than that of allergic rhinitis (4.1 years) but higher than that of atopic dermatitis (0.4 years), IgE-mediated food allergy (1 year), and asthma (1.1 years).

Atopic dermatitis (hazard ratio [HR], 2.7, 95 percent confidence interval [CI], 1.9–4.0), IgE-mediated food allergy (HR, 8.9, 95 percent CI, 6.3–12.4), and asthma (HR, 2.2, 95 percent CI, 1.6–3.1) were independently associated with an elevated risk for eosinophilic oesophagitis. [AAAAI/WAO 2018, abstract 274]

In contrast, eosinophilic oesophagitis was significantly associated with an elevated risk of developing subsequent allergic rhinitis (HR, 3.8, 95 percent CI, 1.4–2.7).

The cumulative effect of the various atopic conditions on the risk of eosinophilic oesophagitis increased with the number of conditions (HR, 3.9, 95 percent CI, 2.6–5.7; HR, 6.5, 95 percent CI, 4.3–9.9; HR, 9.8, 95 percent CI, 5.8–16.8; and HR, 12.2, 95 percent CI, 5.0–30.0 for one, two, three, and four conditions, respectively; p≤0.001 for all associations).

“[Atopic dermatitis, IgE-mediated food allergy, and asthma] independently and cumulatively increase the risk of subsequent eosinophilic oesophagitis, while eosinophilic oesophagitis increases the risk of subsequent allergic rhinitis,” said the researchers.

“If a child was diagnosed with all three conditions, they are even more likely to develop eosinophilic oesophagitis than if they only had one or two other conditions,” said Spergel.

 

Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
5 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.